Albendazole: all 73 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Expanding Access to Preventive Chemotherapy Among Mobile and Migrant PopulationsRecruitingNCT07707817Not applicable
• Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and PraziquantelRecruitingNCT07074444Not applicable
• 21-day Double-blind Trial of Albendazole in Adults With Loa Loa MicrofilaremiaNot yet recruitingNCT06613997Phase 3
• The Role of Adjuvant Albendazole After Pulmonary Hydatid Cyst ResectionRecruitingNCT06483880Not applicable
• Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal NeurocysticercosisNot yet recruitingNCT06376396Phase 4
• Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed ConditionsCompletedNCT06201559Phase 1Results posted
• Efficacy and Safety of Moxidectin-Albendazole Co-administration in SACCompletedNCT06188715Phase 3Results posted
• HIV And Parasitic Infection (HAPI) StudyCompletedNCT05323396Not applicableResults posted
• Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus InfectionTerminatedNCT04913610Phase 2Results posted
• Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administrationCompletedNCT04700423Phase 2/3Results posted
• Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant AlbendazoleCompletedNCT04311671Phase 3Results posted
• Albendazole Dose Finding and Pharmacokinetics in Children and AdultsCompletedNCT03527745Phase 2Results posted
• Efficacy and Safety of IVM/ALB Co-administrationCompletedNCT03527732Phase 2/3Results posted
• Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)CompletedNCT03014167Phase 3Results posted
• Bioequivalence Study of Albendazole 400 mg Tablets in Chinese PopulationCompletedNCT01755637Phase 1Results posted
• Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in MalawiTerminatedNCT01213576Not applicableResults posted
• Effect of Albendazole Dose on Treatment of Lymphatic FilariasisCompletedNCT00511004Phase 2Results posted
• Safety and Efficacy of Novel Combination Regimens for Treatment of OnchocerciasisActive, not recruitingNCT06070116Phase 2
• Pharmacokinetics and Excretion of Albendazole and Its Metabolites in SalivaStatus unknownNCT05453045Not applicable
• Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African ChildrenStatus unknownNCT05354258Not applicable
• The Effectiveness of Albendazole Treatment Among Infected Toxocara ChildrenStatus unknownNCT05208333Not applicable
• Parasitic Infection in Anemic Pregnant WomenStatus unknownNCT04391998Phase 4
• Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in GabonCompletedNCT04326868Phase 4
• SANCC: Clinical Trial Early InterventionWithdrawnNCT03950037Phase 2
• PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03664063Phase 2
• Triple Combinations Against Hookworm Infections in LaoCompletedNCT03278431Phase 4
• IVM Alone vs ALB + IVM Against OnchocerciasisCompletedNCT03238131Phase 3
• Effect of Routine Deworming on Weight of ChildrenCompletedNCT03155035Not applicable
• Intestinal Microbiome Post-Azythromycin/Albendazole TreatmentWithdrawnNCT03032042Phase 4
• Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO)TerminatedNCT02947581Phase 3
• The Bangladesh Environmental Enteric Dysfunction StudyStatus unknownNCT02812615Not applicable
• Effect of Hookworm Elimination and Vitamin A Intervention on Iron Status of Preschool Children in Sichuan, ChinaCompletedNCT02675140Phase 4
• Impact of Periodontal Treatment on Serum Levels of Hepcidin and HemoglobinCompletedNCT02641210Phase 4
• The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School ChildrenWithdrawnNCT02597556Phase 4
• Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in KenyaCompletedNCT02397772Phase 4
• Package of Interventions After Recovering From Moderate Acute MalnutritionCompletedNCT02351687Not applicable
• Combined Package of Interventions for Environmental EnteropathyCompletedNCT02253095Not applicable
• Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CTCompletedNCT02243644Phase 3
• Does Treating Hookworm Improve Productivity of Small Subsistence FarmersStatus unknownNCT02102321Not applicable
• Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti InfectionCompletedNCT02005653Phase 4
• Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic FilariasisWithdrawnNCT01903057Phase 4
• Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyCompletedNCT01825031Phase 3
• Postpartum Deworming: Improving Breastfeeding and Optimizing Infant GrowthCompletedNCT01748929Phase 4
• Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis EliminationCompletedNCT01586169Not applicable
• A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment OutcomesStatus unknownNCT01541631Not applicable
• Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, GhanaStatus unknownNCT01459146Phase 4
• Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental EnteropathyCompletedNCT01440608Not applicable
• Effectiveness of Oral Albendazole in the Treatment of Severe Acute MalnutritionWithdrawnNCT01395381Not applicable
• The Efficacy of Five Anthelmintic Regimes Against Trichuris Trichiura Infections in Schoolchildren in Jimma, EthiopiaCompletedNCT01327469Phase 4
• Management of Soil-transmitted Helminthiasis and StrongyloidiasisStatus unknownNCT01308268Not applicable
• Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut MicrofloraCompletedNCT01192802Phase 4
• A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in ChildrenCompletedNCT01087099Phase 4
• Antiparasitic Treatment for Returning Travelers With Chronic DiarrheaStatus unknownNCT01070277Not applicable
• A Community Trial for Visceral Leishmaniasis (VL)CompletedNCT01069198Not applicable
• Safety and Efficacy of Drug Combinations Against Triple InfectionsCompletedNCT01050517Not applicable
• Safety and Efficacy of Drug Combinations Against Trichuris TrichiuraCompletedNCT01050452Not applicable
• Studies of Immune Responses to Orally Administered Vaccines in Developing CountryCompletedNCT01019083Phase 1/2
• Deworming Against TuberculosisCompletedNCT00857116Not applicable
• Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?TerminatedNCT00817713Not applicable
• Treatment of Asymptomatic Toxocariasis With Albendazole in ChildrenActive, not recruitingNCT00755560Phase 3
• Efficacy Albendazole and Levamisole Against STH on UngujaCompletedNCT00659997Phase 4
• Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease ProgressionCompletedNCT00507221Not applicable
• Relative Efficacy of Two Regimens of Ante-helminthic TreatmentCompletedNCT00367627Not applicable
• Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, TanzaniaCompletedNCT00347113Not applicable
• Effect of Mass Deworming on Child GrowthCompletedNCT00344669Not applicable
• Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00339417Phase 2
• Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis PatientsCompletedNCT00290823Phase 3
• A Pilot Study of Neurocysticercosis TreatmentCompletedNCT00283699Phase 3
• Epidemiology and Control of Mansonella Perstans Infection in UgandaCompletedNCT00215280Not applicable
• RCT ALB for SA CysticercosisWithdrawnNCT00133458Phase 3
• Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune ActivationCompletedNCT00130910Not applicable
• Randomized Study of Albendazole in Patients With Epilepsy Due to NeurocysticercosisCompletedNCT00004403Not applicable
• A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal MicrosporidiosisCompletedNCT00002191Phase 3

← Albendazole overview